This patent application is for a physiological saline solution containing graphene. It describes dispersing graphene powder less than 1nm in size into saline solutions, Ringers solution, or dextrose in water. The graphene-containing solutions can be used to treat diseases like dementia, Parkinson's, and viruses. The graphene adheres to virus particles and prevents them from acting on the human body. Surfactants or other additives may be included to improve graphene dispersion and prevent particle coagulation over time. Priority is claimed for earlier Korean patent applications.
Graphene and ionic liquid matrices for metallodrug and bacteria analysisHani Nasser Abdelhamid
This document discusses the use of graphene and ionic liquids for analyzing pathogenic bacteria and metallodrugs using mass spectrometry techniques. It describes how graphene and various ionic liquid matrices can improve the analysis of bacteria and metallodrugs over conventional matrixes when used in matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). The document presents results demonstrating that the ionic liquid matrices provide lower detection limits, improved peak resolution and reduced interference when analyzing bacteria and metallodrug complexes compared to traditional matrixes. In conclusion, the ionic liquid matrixes were shown to improve the analysis of pathogenic bacteria and metallodrugs using MALDI-MS.
This patent application describes dispersible concentrate (DC) compositions containing metconazole, non-ionic surfactants, and solvents. The compositions form nano-suspensions of metconazole particles less than 30 nm when diluted with water. The compositions provide improved dispersion properties and biological efficacy compared to other metconazole formulations. Methods of preparing nano-suspensions and ready-to-use products from the DC compositions are also disclosed for treating plants to protect against fungi.
This document summarizes a study on the removal of Safranin dye from aqueous solution using sodium phosphate (NaP) zeolite synthesized from coal fly ash. The study investigated the thermodynamic and kinetic properties of Safranin dye adsorption onto the synthesized zeolite. Characterization techniques including XRF, SEM, XRD and FTIR were used to analyze the zeolite. Batch adsorption experiments showed maximum dye removal of 97.14% at an equilibrium pH of 9.0, adsorbent dose of 5 g/L, and contact time of 180 minutes. Adsorption data fitted well to Langmuir and Freundlich isotherm models. Kinetic data showed best fit
The document summarizes the synthesis and characterization of zeolite from coal fly ash and its application in removing inorganic and organic pollutants from wastewater. Key points:
- Zeolite was synthesized from coal fly ash via an alkali fusion process followed by hydrothermal treatment. The synthesized zeolite was characterized using various techniques.
- Batch adsorption studies were conducted to investigate the ability of synthesized zeolite to remove heavy metals like copper, cadmium, lead and dye (safranin) from wastewater. Parameters like contact time, dose, pH and concentration were optimized.
- Adsorption isotherm models like Langmuir, Freundlich, Tem
This document contains a complaint filed with the International Criminal Court alleging numerous violations of international law by officials in the UK related to their COVID-19 response. It alleges violations of the Nuremberg Code, crimes against humanity, war crimes, and crimes of aggression. It provides background on issues like the experimental nature of COVID vaccines, inaccuracies with PCR testing, evidence that COVID may be a biological weapon resulting from gain-of-function research, inclusion of potentially harmful graphene hydroxide in vaccines, inflation of COVID case and death figures, ineffectiveness of masks, and suppression of alternative treatments. The complaint requests a full investigation.
EXHIBIT A
V A C C I N E - A N A L Y S I S - B Y - D R . R O B E R T - Y O U NG
Graphene Oxide; also known as G.O. is a compound of magnetic nanoparticles.
Graphene and ionic liquid matrices for metallodrug and bacteria analysisHani Nasser Abdelhamid
This document discusses the use of graphene and ionic liquids for analyzing pathogenic bacteria and metallodrugs using mass spectrometry techniques. It describes how graphene and various ionic liquid matrices can improve the analysis of bacteria and metallodrugs over conventional matrixes when used in matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). The document presents results demonstrating that the ionic liquid matrices provide lower detection limits, improved peak resolution and reduced interference when analyzing bacteria and metallodrug complexes compared to traditional matrixes. In conclusion, the ionic liquid matrixes were shown to improve the analysis of pathogenic bacteria and metallodrugs using MALDI-MS.
This patent application describes dispersible concentrate (DC) compositions containing metconazole, non-ionic surfactants, and solvents. The compositions form nano-suspensions of metconazole particles less than 30 nm when diluted with water. The compositions provide improved dispersion properties and biological efficacy compared to other metconazole formulations. Methods of preparing nano-suspensions and ready-to-use products from the DC compositions are also disclosed for treating plants to protect against fungi.
This document summarizes a study on the removal of Safranin dye from aqueous solution using sodium phosphate (NaP) zeolite synthesized from coal fly ash. The study investigated the thermodynamic and kinetic properties of Safranin dye adsorption onto the synthesized zeolite. Characterization techniques including XRF, SEM, XRD and FTIR were used to analyze the zeolite. Batch adsorption experiments showed maximum dye removal of 97.14% at an equilibrium pH of 9.0, adsorbent dose of 5 g/L, and contact time of 180 minutes. Adsorption data fitted well to Langmuir and Freundlich isotherm models. Kinetic data showed best fit
The document summarizes the synthesis and characterization of zeolite from coal fly ash and its application in removing inorganic and organic pollutants from wastewater. Key points:
- Zeolite was synthesized from coal fly ash via an alkali fusion process followed by hydrothermal treatment. The synthesized zeolite was characterized using various techniques.
- Batch adsorption studies were conducted to investigate the ability of synthesized zeolite to remove heavy metals like copper, cadmium, lead and dye (safranin) from wastewater. Parameters like contact time, dose, pH and concentration were optimized.
- Adsorption isotherm models like Langmuir, Freundlich, Tem
This document contains a complaint filed with the International Criminal Court alleging numerous violations of international law by officials in the UK related to their COVID-19 response. It alleges violations of the Nuremberg Code, crimes against humanity, war crimes, and crimes of aggression. It provides background on issues like the experimental nature of COVID vaccines, inaccuracies with PCR testing, evidence that COVID may be a biological weapon resulting from gain-of-function research, inclusion of potentially harmful graphene hydroxide in vaccines, inflation of COVID case and death figures, ineffectiveness of masks, and suppression of alternative treatments. The complaint requests a full investigation.
EXHIBIT A
V A C C I N E - A N A L Y S I S - B Y - D R . R O B E R T - Y O U NG
Graphene Oxide; also known as G.O. is a compound of magnetic nanoparticles.
CARTA ABIERTA A TODO ARGENTINO QUE TENGA DE ALGUNA MANERA RESPONSABILIDAD SOBRE LOS NIÑOS Y ADOLESCENTES
10 de octubre de 2021
Dra. Liliana Szabó- DNI 11912668- Médica pediatra- MN 57156-
Miembro Titular de la Sociedad Argentina de Pediatría (en adelante SAP) Socia nº 2592-
This document reports evidence that millions have died from the COVID-19 vaccines worldwide based on analyses of various data sources. It claims that official reports vastly undercount deaths and side effects. Whistleblowers allege the US death count is 5-10 times higher than reported. Experts warn the vaccines may be causing the greatest risk of genocide in history and call for stopping their rollout. However, the claims require careful verification and consideration of multiple perspectives given the controversial nature of the topic.
This document discusses recent discoveries of transgenic hydra and parasites found in COVID vaccines. It claims that hydra and parasites have been genetically modified and are being used as part of a "vaccine operating system" to rewrite human genes, build an artificial neural network, and rapidly clone humans. The document outlines scientific studies it says were used to develop this system using techniques like CRISPR, mRNA, graphene oxide, and luciferase to track and control gene expression in vaccinated individuals.
The document is a United States patent describing methods for producing recombinant coronavirus particles. Specifically, it describes developing a helper cell that contains: 1) a coronavirus permissive cell; 2) a coronavirus replicon RNA containing a heterologous sequence and packaging signal but lacking a structural protein gene; and 3) a separate helper RNA encoding the missing structural protein. When these components are expressed in the cell, coronavirus particles are assembled that contain the heterologous RNA sequence but cannot replicate without the helper RNA. The patent claims compositions and methods for making and using these viral particles to deliver heterologous genes.
La Dirección General de Medicamentos, Insumos y Drogas (Digemid) del Ministerio de Salud (Minsa) PERÚ, advirtió respecto a la aparición de algunos posibles casos de miocarditis y pericarditis reportados en los Estados Unidos tras la inmunización contra el COVID-19 con vacunas que utilizan la plataforma de ARN mensajero (ARNm).
Este documento presenta una introducción al Manual de Ética Médica. Explica brevemente qué es la ética médica y por qué es importante estudiarla. También distingue entre ética médica, profesionalismo médico, derechos humanos y derecho. Finalmente, concluye que la ética médica enfrenta interrogantes sobre valores, derechos y responsabilidades del médico.
This document provides an updated action plan for global COVID-19 vaccination from The Rockefeller Foundation. It summarizes the current unequal distribution of vaccines, with only a small percentage of people in Africa, Asia, and South America receiving doses compared to half in North America and a quarter in Europe. The plan calls for wealthy countries to share more of their surplus vaccine doses sooner to help address this inequity. It also recommends accelerating support for vaccine delivery systems in developing countries, closing the $18.5 billion funding gap for the ACT-A initiative including the $9.3 billion needed for COVAX, and establishing vaccine production capacity in Africa, Asia, and South America to ensure equitable access to vaccines and prepare for future pandem
The Fauci/COVID-19 Dossier
This work was supported, in part, by a fund-raising effort in which approximately 330 persons contributed funds in support
of the New Earth technology team and Urban Global Health Alliance. It is released under a Creative Commons license CCBY-NC-SA
. INVESTIGACION SOBRE LA TOXICIDAD Y NO TOXICIDAD SOBRE USO DEL DIÓXIDO DE CLORO SATURADO
EN AGUA A DOSIS ADECUADAS PARA EL CONSUMO HUMANO COMO COADYUVANTE EN EL TRATAMIENTO
DEL SARS-COV2, COVID 19
INFORME DE CONTRAINTELIGENCIA GLOBAL DE LUCHA CONTRA EL COVID
ECUADOR 22/04/2021
REPORTE HECHO POR INVESTIGADORES Y CIENTIFICOS DEL TERRITORIO ECUATORIANO.
ESTABLECIMIENTOS, UNIVERSIDADES Y DEMAS HAN APORTADO DE CARÁCTER SIGNIFICATIVO RESPUESTAS
NO SOLO DE VERACIDAD CIENTIFICA SINO DE HECHOS PROPIOS DEL TERRITORIO ECUATORIANO Y APOYADO
DE SUSTENTACIONES DE TAMBIEN GRANDES CIENTIFICOS, INVESTIGADORES, ACTIVISTAS PROFESIONALES Y NO PROFESIONALES EN TODO EL MUNDO A FAVOR DE LA VIDA Y DE LA VERDAD INCLUSO QUE HAN COSTADO VIDAS COMO LA DE LOS DOCTORES QUE ADVIRTIERON SOBRE EL VIRUS SARS COVID 19
Que denunciaron la ocultación de información y la negligencia en la agilidad de transmitir la información sobre el virus y como prevenirlo.
El documento describe estudios realizados sobre películas de carragenina reforzadas con nanowhiskers de quitina. Los estudios incluyeron ensayos mecánicos que mostraron un aumento significativo en el módulo de Young y resistencia a la tracción de las películas reforzadas. También se realizaron ensayos morfológicos mediante microscopía electrónica que revelaron una dispersión no homogénea de los nanowhiskers. Además, se estudiaron nanocompuestos de carragenina reforz
“CARACTERIZACIÓN DE NANOMATERIALES COMPUESTOS CON MATRIZ DE
CARRAGENINA REFORZADOS CON ÓXIDO DE GRAFENO, NANOTUBOS DE
CARBONO Y NANOPARTÍCULAS DE ORIGEN BIOLÓGICO”
David Ortecho
Universidad Católica
Petición al presidente y ministro de salud 28 05 2021
Solicitud legal para la adopción urgente de medidas y acciones competentes con el fin de restablecer la garantía
efectiva del orden constitucional, jurídico y social
Cartagena - Colombia
Solicitud en uso del derecho de petición Articulo 23 CPN, respuesta de acciones
desarrolladas y entrega formal certificaciones y pruebas, sobre términos y contenido de las
vacunas Covid -19, responsabilidad civil y penal de laboratorios y el gobierno, inoculación
vacuna, Covid -19, y debido aporte de certificaciones y pruebas aquí solicitadas
Santa Fe de Bogotá. Colombia
Demanda fiscalía provincial Loja Ecuador
Contaminación del agua, el aire ( medio ambiente ) por TECNOLOGÍA 5G, PCR FRAUDULENTAS Y VACUNAS EXPERIMENTALES ASESINAS
Fiscalía provincial de Loja - Ecuador
CARTA ABIERTA A TODO ARGENTINO QUE TENGA DE ALGUNA MANERA RESPONSABILIDAD SOBRE LOS NIÑOS Y ADOLESCENTES
10 de octubre de 2021
Dra. Liliana Szabó- DNI 11912668- Médica pediatra- MN 57156-
Miembro Titular de la Sociedad Argentina de Pediatría (en adelante SAP) Socia nº 2592-
This document reports evidence that millions have died from the COVID-19 vaccines worldwide based on analyses of various data sources. It claims that official reports vastly undercount deaths and side effects. Whistleblowers allege the US death count is 5-10 times higher than reported. Experts warn the vaccines may be causing the greatest risk of genocide in history and call for stopping their rollout. However, the claims require careful verification and consideration of multiple perspectives given the controversial nature of the topic.
This document discusses recent discoveries of transgenic hydra and parasites found in COVID vaccines. It claims that hydra and parasites have been genetically modified and are being used as part of a "vaccine operating system" to rewrite human genes, build an artificial neural network, and rapidly clone humans. The document outlines scientific studies it says were used to develop this system using techniques like CRISPR, mRNA, graphene oxide, and luciferase to track and control gene expression in vaccinated individuals.
The document is a United States patent describing methods for producing recombinant coronavirus particles. Specifically, it describes developing a helper cell that contains: 1) a coronavirus permissive cell; 2) a coronavirus replicon RNA containing a heterologous sequence and packaging signal but lacking a structural protein gene; and 3) a separate helper RNA encoding the missing structural protein. When these components are expressed in the cell, coronavirus particles are assembled that contain the heterologous RNA sequence but cannot replicate without the helper RNA. The patent claims compositions and methods for making and using these viral particles to deliver heterologous genes.
La Dirección General de Medicamentos, Insumos y Drogas (Digemid) del Ministerio de Salud (Minsa) PERÚ, advirtió respecto a la aparición de algunos posibles casos de miocarditis y pericarditis reportados en los Estados Unidos tras la inmunización contra el COVID-19 con vacunas que utilizan la plataforma de ARN mensajero (ARNm).
Este documento presenta una introducción al Manual de Ética Médica. Explica brevemente qué es la ética médica y por qué es importante estudiarla. También distingue entre ética médica, profesionalismo médico, derechos humanos y derecho. Finalmente, concluye que la ética médica enfrenta interrogantes sobre valores, derechos y responsabilidades del médico.
This document provides an updated action plan for global COVID-19 vaccination from The Rockefeller Foundation. It summarizes the current unequal distribution of vaccines, with only a small percentage of people in Africa, Asia, and South America receiving doses compared to half in North America and a quarter in Europe. The plan calls for wealthy countries to share more of their surplus vaccine doses sooner to help address this inequity. It also recommends accelerating support for vaccine delivery systems in developing countries, closing the $18.5 billion funding gap for the ACT-A initiative including the $9.3 billion needed for COVAX, and establishing vaccine production capacity in Africa, Asia, and South America to ensure equitable access to vaccines and prepare for future pandem
The Fauci/COVID-19 Dossier
This work was supported, in part, by a fund-raising effort in which approximately 330 persons contributed funds in support
of the New Earth technology team and Urban Global Health Alliance. It is released under a Creative Commons license CCBY-NC-SA
. INVESTIGACION SOBRE LA TOXICIDAD Y NO TOXICIDAD SOBRE USO DEL DIÓXIDO DE CLORO SATURADO
EN AGUA A DOSIS ADECUADAS PARA EL CONSUMO HUMANO COMO COADYUVANTE EN EL TRATAMIENTO
DEL SARS-COV2, COVID 19
INFORME DE CONTRAINTELIGENCIA GLOBAL DE LUCHA CONTRA EL COVID
ECUADOR 22/04/2021
REPORTE HECHO POR INVESTIGADORES Y CIENTIFICOS DEL TERRITORIO ECUATORIANO.
ESTABLECIMIENTOS, UNIVERSIDADES Y DEMAS HAN APORTADO DE CARÁCTER SIGNIFICATIVO RESPUESTAS
NO SOLO DE VERACIDAD CIENTIFICA SINO DE HECHOS PROPIOS DEL TERRITORIO ECUATORIANO Y APOYADO
DE SUSTENTACIONES DE TAMBIEN GRANDES CIENTIFICOS, INVESTIGADORES, ACTIVISTAS PROFESIONALES Y NO PROFESIONALES EN TODO EL MUNDO A FAVOR DE LA VIDA Y DE LA VERDAD INCLUSO QUE HAN COSTADO VIDAS COMO LA DE LOS DOCTORES QUE ADVIRTIERON SOBRE EL VIRUS SARS COVID 19
Que denunciaron la ocultación de información y la negligencia en la agilidad de transmitir la información sobre el virus y como prevenirlo.
El documento describe estudios realizados sobre películas de carragenina reforzadas con nanowhiskers de quitina. Los estudios incluyeron ensayos mecánicos que mostraron un aumento significativo en el módulo de Young y resistencia a la tracción de las películas reforzadas. También se realizaron ensayos morfológicos mediante microscopía electrónica que revelaron una dispersión no homogénea de los nanowhiskers. Además, se estudiaron nanocompuestos de carragenina reforz
“CARACTERIZACIÓN DE NANOMATERIALES COMPUESTOS CON MATRIZ DE
CARRAGENINA REFORZADOS CON ÓXIDO DE GRAFENO, NANOTUBOS DE
CARBONO Y NANOPARTÍCULAS DE ORIGEN BIOLÓGICO”
David Ortecho
Universidad Católica
Petición al presidente y ministro de salud 28 05 2021
Solicitud legal para la adopción urgente de medidas y acciones competentes con el fin de restablecer la garantía
efectiva del orden constitucional, jurídico y social
Cartagena - Colombia
Solicitud en uso del derecho de petición Articulo 23 CPN, respuesta de acciones
desarrolladas y entrega formal certificaciones y pruebas, sobre términos y contenido de las
vacunas Covid -19, responsabilidad civil y penal de laboratorios y el gobierno, inoculación
vacuna, Covid -19, y debido aporte de certificaciones y pruebas aquí solicitadas
Santa Fe de Bogotá. Colombia
Demanda fiscalía provincial Loja Ecuador
Contaminación del agua, el aire ( medio ambiente ) por TECNOLOGÍA 5G, PCR FRAUDULENTAS Y VACUNAS EXPERIMENTALES ASESINAS
Fiscalía provincial de Loja - Ecuador
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Hiranandani Hospital in Powai, Mumbai, is a premier healthcare institution that has been serving the community with exceptional medical care since its establishment. As a part of the renowned Hiranandani Group, the hospital is committed to delivering world-class healthcare services across a wide range of specialties, including kidney transplantation. With its state-of-the-art facilities, advanced medical technology, and a team of highly skilled healthcare professionals, Hiranandani Hospital has earned a reputation as a trusted name in the healthcare industry. The hospital's patient-centric approach, coupled with its focus on innovation and excellence, ensures that patients receive the highest standard of care in a compassionate and supportive environment.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
4. 【Description of the Invention】
【Title of Invention】
The saline solution [Physiological Saline Containing Graphene] in which the
graphene is dispersed and contained.
【Technical Field】
【0001】 The present invention relates to the injection solution, the saline
solution, the dextrose in water, the Ringers solution etc placed with the
purpose of curing the disease on the blood vessel of the human body, and the
subcutaneous tissue.
【0002】 The saline solution in which the graphene of the invention is dispersed
and contained tries to utilize for each disease including the dementia disease,
parkinson's disease, amyotrophic lateral sclerosis, the Huntington disease etc.
【0003】 The saline solution in which the graphene of the invention is dispersed
and contained tries to utilize as the therapeutic agent of etc. all viruses as ***,
SARS, and the nose.
【0004】 The graphene powder of size less than 0.2nm in the means of using as
the injection solution, the Ringers solution, the saline solution, the injection
solution including the dextrose in water etc used in the conventional hospital
can be used as the therapeutic agent it is scattered.
【Background Technique】
【0005】 [Patent documents 1] , application No: 10-2012-0037752, and the
application date: 2012 year April 12, and the title of invention: the composition
for the formation to the injectable one oxide graphene digitize, and the
hydrogel manufacturing method using the same and in vivo gel formation
method using the same it reacts to the outside stimulus.
【Content of Invention】
5. 【Problem to solve】
【0006】 In the present invention, the graphene of 0.2nm in the saline solution
which the problem supplies the human body to the injection agent or the
Ringers solution can be used as the therapeutic agent of the disease it is
scattered.
【Solution to the Problem】
【0007】 In the present invention, the powder graphene less than 0.2nm in the
saline solution supplied to the means for solving problems to the human body
to the injection agent, the Ringers solution, and the drinking liquid can be
used as the therapeutic agent of the disease it is scattered.
【Effect of Invention】
【0008】 The saline solution in which the graphene of the invention is dispersed
and contained can use in each disease including the dementia disease,
parkinson's disease, amyotrophic lateral sclerosis, the Huntington disease
etc.
【0009】 The saline solution in which the graphene of the invention is dispersed
and contained can use in the virus each disease including ***, SARS, and the
nose etc.
【Description of Drawings】
【0010】 Fig. 1 is the model map of the virus (100).
The perspective view of the process where fig. 2 the graphene powder (20)
unites with the spike protrusion (12) of the virus (100).
The perspective view in which the graphene powder (20) fig. 3 is combined
in the spike protrusion (12) of the virus (100) and the spike protrusion (12) is
altogether seen having with the Cha DoenDoe.
【Detailed Description for the Implementation of the Invention】
6. 【0011】 The present invention relates to the saline solution in which the
graphene is dispersed and contained, and it hereinafter illustrates in detail.
【0012】 The present invention relates to the injection solution, the saline
solution, the dextrose in water, the Ringers solution placed with the purpose
of curing the disease on the blood vessel of the human body, and the
subcutaneous tissue.
【0013】 First, the saline solution is illustrated.
【0014】 The isotonic liquid which thinks the body fluid of the cage condition as
0.9% NaCl solution and which adjusts identically this and concentration and
which concentration manufacture is referred to.
【0015】 Even if the saline solution injects through the ringer etc. because the
change of the osmotic pressure is not aroused to the general water even if it
directly comes in within the blood vessel the symptoms including shock etc. is
not shown up.
【0016】 If the emergency patient is taken to hospital due to the physiological
sodium chloride solution or it does, big the Ringers solution (Ringer's solution)
supplies the direct sap to the blood vessel and the purpose is made.
【0017】 Or glucose another name Ringer`s solution is contained with water and
salinity, the nutraceutical, the antibiotic etc.
【0018】 In the Ringers solution, ATP and glucose (dextrose) are contained to
the sodium chloride (salt), KCL, calcium chloride, sodium bicarbonate and
nutraceutical.
【0019】 It is the name of the important metabolite quality in which the
abbreviation of the adenosin triphosphate food is digested and in which ATP is
generated in the cell in the process of being used as energy.
【0020】 It is the nutrient which it administers to the patient when being not
given condition in which the patient receives food and which ATP and glucose
assimilate and which is most essential.
7. 【0021】 Or the direct injection is placed with the injection agent on the arm
or the hips or the affected part and neighbouring subcutaneous tissue and it
supplies.
【0022】 In the present invention, the saline solution, dextrose in water, ringers
solution, the injection solution etc is named as the saline solution and it
illustrates.
【0023】 That is, the graphene is and adds dispersed in the saline solution and it
uses
【0024】 The saline solution in which the graphene is contained establishes to
the concept including the dextrose in water, the Ringers solution, the injection
solution etc. and it illustrates.
【0025】 In conventional Ringers solution 1 liters (1,000ml), the salinity (sodium
chloride NaCI) which the concentration of the salinity included in the blood of
the human body was similar was about 9g ***.
【0026】 Because it is similar with the density of salt of the blood of the human
body because of being the isotonic liquid (isotonic solution) this concentration
calls.
【0027】 Hereinafter, the graphene is illustrated.
【0028】 The graphene is divided into two categories.
【0029】 While indicating the large area sheet connected to the hexagonal loop
as to the graphene sheet, the atom of graphite makes the atom thickness using
the CVD deposition instrument and the research is active.
【0030】 The graphene sheet mainly utilizes in the semiconductor.
【0031】 It is the powder in which the graphene, and, one class is made into the
punctiform of the atom thickness of graphite.
【0032】 In the present invention, 0.1nm to the powder made with 1nm the
generally is named as the graphene powder and graphite or the carbon
(charcoal) is used.
8. 【0033】 Or it indicates that the graphene makes carbon the powder of 0.1nm to
1nm.
【0034】 Carbon chars the organic compound.
【0035】 That is, the organic compound can be used as the powder, which chars
and which makes the carbon (male) and which it processes to the powder of
0.1nm to 1nm and made in the present invention, the graphene.
【0036】 It dispatches to the human body of the patient by because of being the
graphene the invention defining the size powder less than 1nm of graphite or
carbon and the graphene being and adds dispersed in the saline solution and
the saline solution in which the graphene is dispersed and contained being
made and using as the drink number, the injection agent, the ringer injection
the etc. and it tries to be the purpose of being stupid with prevention and
treatment the disease comprised.
【0037】 The gas is reacted and the graphene powder produces.
【0038】 The graphene powder is classified into the non-oxidizing graphene, the
oxide graphene, and the reduction graphene.
【0039】 The non-oxidizing graphene, the oxide graphene, and the reduction
graphene field can be used.
【0040】 But preferably, it is to use the non-oxidizing graphene.
【0041】 In the present invention, the fullerene of the shape of a soccer ball
which is the carbon isotope can be used for the large of the graphene.
【0042】 Hereinafter, the organism graphene is illustrated.
【0043】 The carbon charring the plant class, ascidian, animal class, fishes,
insect species, creatures including the fungus etc which is the creature
existing in district to the ashing and is made is processed to size less than 1nm
and the organism graphene is made and it can use.
【0044】 The carbon which chars and in which the plant of the creature is the
stem, leaf, root, berries, flower etc made into the ashing is processed to size
9. less than 1nm and the organism graphene is made and it can use.
【0045】 Moreover, the sap, collected in the stem, leaf, root, berries, flower etc
of the creature or the honey, sugar etc. are dried and the carbon made after
the ashing is processed to size less than 1nm and the organism graphene is
made and it can use.
【0046】 The animal class, the fishes, the insect species etc. process the carbon
charring and is the protein, bone etc. made into the ashing to size less than
1nm and the organism graphene is made and it can use.
【0047】 The carbon charring the fungus of the creature to the ashing and is
made is processed to size less than 1nm and the organism graphene is made
and it can use.
【0048】 In the present invention, it says to be the powder of size less than 1nm
in which the organism graphene makes charcoal the creature with the drying
procedure, and the ashing and which is crushed and processed charcoal to the
grinding process the organism graphene lice.
【0049】 That is, the numerically is of 0.01nm to 1nm since the organism
graphene is the size of less than of 1nm.
【0050】 In the present invention, the organism graphene can be used as the
gathering of the powder of size less than 1nm it uses as the saline solution in
which the graphene of the invention is dispersed and contained
【0051】 Or the powder of the size of the specific range selected from the powder
of the size of 0.01nm to 1nm
【0052】 Or it can use as the gathering of the selected specific range among the
powder of the size of 0.01nm to 1nm.
【0053】 But in the present invention, according to its purpose of
manufacturing, it announces that it enlarges to the range of the size of 0.01nm
to 5nm and the size of the graphene powder or the organism graphene powder
can add.
10. 【0054】 The process of processing graphite or carbon and processing to size
less than 1nm and making the graphene, and the organism graphene does not
illustrate in detail but oneself makes "graphene alpha" company and graphite
is processed before the several years and the graphene is made and oneself
makes with 0.1nm to 0.7nm, and the size of 5nm and it circulates in on the
market.
【0055】 That is, it hopes in their heart to refer to the process of making the
graphene graphite, and the carbon isotope secure and use but yet nots open
the technology of the graphene machining.
【0056】 It has prior arts which are the process of fining the coarse-grained
graphite, and charcoal to the micromachining and which the process of
making the , organism graphene powder the graphene powder with graphite,
charcoal etc. uses in the conventional industrial site and the ball mill texturing
technique remarkably represents.
【0057】 But the yield of the processed powder is not satisfactory to the ball mill
texturing technique to 0.1nm to 1nm.
【0058】 In the present invention, the ashing which the ashing uses in the
current whole industry is followed.
【0059】 In the present invention, the graphene powder 0.000005g to 1g is added
and it disperses into the ultrasonic disperser group or the dispersion means
into the saline solution or Ringers solution 1 liters (1,000ml) and it can use
【0060】 But according to the purpose, amount of the graphene powder chosen
according to its purpose that the graphene powder manufactures at a rate
per the saline solution or Ringers solution 1 liters (1,000ml) is added and it
disperses and it can use.
【0061】 That is, it announces the saline solution or the Ringers solution in
which the graphene is dispersed and contained controlling the graphene
content according to the purpose and being scattered.
11. 【0062】 In the above case, the graphene can be the organism graphene.
【0063】 It has the characteristic in which the nano particle is cohered.
【0064】 That is, it has the characteristic in which particles which are near even
if it disperses the graphene powder into the saline solution or the Ringers
solution if the preset time passes by are cohered.
【0065】 Therefore, it has to use within the time not to the Ringers solution in
which the graphene powder is dispersed long keep and be cohered.
【0066】 But in the present invention, the disadvantage of being cohered of the
graphene nano particle is used as the advantage.
【0067】 That is, the characteristic used as the advantage of blocking that it
sticks when killing the virus because the graphene powder which is 0.1nm to
1nm nano particle sweets on the virus which is the size of 10nm to 1000nm and
the virus acts on the human body is used.
【0068】 But it has the number putting the additive in the saline solution, or the
means of increasing the time to dispersion be facilitated and become with the
nano coherence when adding the graphene in the Ringers solution and being
scattered but it knows.
【0069】 Because the additive uses as the saline solution, or the means of
increasing the time to dispersion be facilitated and become with the nano
coherence when adding the graphene in the Ringers solution and being
scattered in the human body while the surfactant uses the nature surfactant
can be used.
【0070】 While indicating all surfactants that the surfactant uses in the industry
one kind is selected out and it adds.
【0071】 Or the surfactant more than 2 kinds is chosen and it can add and it
follows its selection which the addition amount manufactures.
【0072】 According to the necessity of the surfactant, it adds within the
comparison 10mg of 1 liters (1,000ml) of the saline solution, or the Ringers
12. solution when stubbornly adding.
【0073】 The superspecies class, and the alkali kind can be used as another
additive.
【0074】 According to its purpose of manufacturing, or it stubbornly adds as the
superspecies class within the comparison 5mg of 1 liters (1,000ml) of the saline
solution, or the Ringers solution when adding the alkali component.
【0075】 In the above case, it does that the graphene less than 1nm can be
used since the particle size of the graphene possible to be used in the present
invention 1nm class can use according to the purpose.
【0076】 That is, in the saline solution in which the graphene of the invention is
dispersed and contained, even if it has the product of the situation which is not
surfactant, acidity, or the material in which the alkali component is certainly
added and is added according to its purpose of manufacturing it adds in time
and it can manufacture.
【0077】 In the present invention, the nano-material replacing the graphene
powder is illustrated.
【0078】 It can replace with the powder less than 0.1nm consisting of the organic
material, and the inorganic material to 1nm.
【0079】 That is, it can not be dissolved in water including the calcium
nanopowder, the zinc nanopowder, the magnesium nanopowder etc. and the
graphene can be replaced with the organic material nanopowder which is not
injurious in the condition.
【0080】 That is, it has to be the material which is not dissolved in the liquid
which uses while using the nanopowder which *** consists of the organic
material or the inorganic material with graphene.
【0081】 In the present invention, it can replace with the nano-material
replacing the graphene with the nanopowder of iron.
【0082】 That is, the graphene powder can be replaced with the powder less than
13. 0.1nm of iron to 1nm.
【0083】 In the above case, the saline solution indicates the injection the means
of using of the ringers solution, dextrose in water, buffered saline liquid, the
human body including the injection solution etc.
【0084】 In the present invention, the graphene in the water, the bottled water,
the water purifier water, the distilled water etc which the saline solution or the
Ringers solution and human can drink can be used as the liquid in which the
graphene which it can drink by adding and dispersing and using is dispersed.
【0085】 That is, human as to water, bottled water, water purifier water, the
distilled water etc, which are the liquid means in which the graphene which
human can drink is dispersed can drink.
【0086】 Or the water, bottled water, water purifier water, the distilled water
etc which is the liquid means in which the graphene which human can drink
is dispersed can supply to the direct spray action through the oral cavity of
human or the nostrils using the spray tool.
【0087】 Or the water, bottled water, water purifier water, the distilled water
etc which is the liquid means in which the graphene which human can drink
is dispersed uses as the humidification liquid of the ultra sonic humidifiers
means and the humidification liquid in which the graphene due to the wave
of ultrasound is included can be supplied to the respiratory process to the
breathing organ.
【0088】 According to the drawing attached below, it illustrates whether the
graphene can restrict the virus or not.
【0089】 Fig. 1 shows the model of the virus to drawing.
【0090】 It is parasitic by having to the radial shape with the spike protrusion
outlet and using as the media penetrating into the cell of the human body into
the spike protrusion outside *** and while the cell structure of being perfect is
unable to be formed and the virus exists in the form of the nucleic acid and the
14. protein shell surrounding the nucleic acid the damage is given to the host as
the proliferation process.
【0091】 As shown in fig. 1, in the outside of the body (10) of the virus (100), it
has the characteristic in which the spike protrusion (12) is distributed in the
evenly and it sticks on the human body and it is the chip it is the means.
【0092】 In the present invention, the characteristic of the inside of the body (10)
of the virus (100) is not illustrated.
【0093】 The drawing of the simple model of the virus (100) and graphene
powder are cohered and the some functions of the virus is restricted and it
tries to explain to the extinction it induces.
【0094】 According to the virus (100) is the kind, size is about 10nm to 1000nm.
【0095】 It is used as the means of the what is called spike protrusion (12) in the
external periphery of the body (10) being formed and combined in the cell of
the host and increasing.
【0096】 The object of the present invention binds the graphene powder in the
spike protrusion (12) and the function of the spike protrusion (12) is lost.
【0097】 Figure 2 is a perspective view of the process the graphene powder (20)
uniting with the spike protrusion (12) of the virus (100).
【0098】 It has the purpose in which the graphene powder (20) the combination
(it sticks) in the spike protrusion (12) of the virus (100).
【0099】 That is, it was the needle it was and the virus (100) increased in the
human body or because of being attracted to the power in which the body
evenly grows flushed with the Ringers solution if it has the Ringers solution in
which the graphene powder (20) is dispersed into the treatment method when
doing and it tramps around in the human body and the graphene powder (20)
graphene powder is combined to the nano cohesive force if it meets the virus
(100) and weighing on the body (10) or the spike protrusion (12) of the virus
(100) the power sticks.
15. 【0100】 As shown in fig. 3, if the preset time passes by while the cell is unable
to increase since because the spike protrusion (12) of the virus (100) any more
sweets on the cell of the host if the graphene powder (20) is combined in the
spike protrusion (12) of the virus (100) the cell is unable to stick and it cannot
be parasitic, the cell dies out.
【0101】 It is the nano particle that has the characteristic which is not injurious
upon the human body since it is the carbon isotope in which the graphene
powder (20) configures the condition of carbon the human body.
【0102】 In the above case, the saline solution in which the graphene is
dispersed and contained is injected into the human body using the injection
agent, and the ringer means and the graphene sticks to the virus to the
nano agglomeration and the function of the virus is decreased and the virus
does not increase and it can lead to the road of the extinction in the satellite
exchange.
【0103】 In the above case, the saline solution or the water, bottled water, water
purifier water, the distilled water etc in which the graphene is dispersed and
contained can supply to the direct spray action through the oral cavity of
human or the nostrils using the spray tool.
【0104】 In the above case, the saline solution or the water, bottled water, water
purifier water, the distilled water etc in which the graphene is dispersed and
contained uses as the humidification liquid of the ultra sonic humidifiers
means and the humidification liquid in which the graphene due to the wave
of ultrasound is included can be supplied to the respiratory process to the
breathing organ.
【0105】 That is, the graphene powder or the water in which the organism
graphene powder is contained is vaporized into steam and the steam is inhaled
and the graphene powder or the organism graphene powder reaches the lungs
of the user and it does with the virus and nano combination.
16. 【0106】 Hereinafter, another one example is illustrated.
【0107】 In advance, the electron tobacco is illustrated.
【0108】 It is the electronic cigarette means doing the action which vaporizes
liquid of the cotton means in the heat in which liquid is absorbed into the
cotton means in which the electronic cigarette adds additive (the perfume, and
the nicotine) etc. in the liquid (glycerine) and playing the wick role and had on
and configuring the heating line in the cotton means and heating the heating
line with the battery method and which is generated and made with the aerosol
type and inhaling the haze with the mouth in the exit path and sending to the
lungs and which again makes through the mouth and spit out.
【0109】 In the present invention, to the glycerine, which is the liquid can use in
the electronic cigarette substitution, liquid
【0110】 The saline solution in which the graphene is dispersed and contained
can be substitutively used.
【0111】 In the present invention, the graphene powder is added to the rate
chosen within 1g and it evenly disperses into liquid glycerine 1 liters (1,000ml)
used in the electronic cigarette and it uses.
【0112】 Or the saline solution and the glycerine in which the graphene is
dispersed and contained can be used as the liquid of the electronic cigarette it
evenly mixes to 5 to 5.
【0113】 That is, the graphene nanopowder gets mixed in the haze generated
using the liquid in which the graphene is contained in the liquid of the
electronic cigarette and the breathing organ is passed through the oral cavity
and it reaches even the lungs and the Intention-to-treat can be achieved.
【0114】 The saline solution in which the graphene of the invention is dispersed
and contained is to the Intention-to-treat of dementia to injection, and the
ringer means in the human body.
【0115】 The saline solution in which the graphene of the invention is dispersed
17. and contained is to the Intention-to-treat of the Alzheimer to injection, and the
ringer means in the human body.
【0116】 The saline solution in which the graphene of the invention is dispersed
and contained is to the Intention-to-treat of the Lou Gehrig disease to
injection, and the ringer means in the human body.
【0117】 The saline solution in which the graphene of the invention is dispersed
and contained is to the Intention-to-treat of the Parkinson disorder to
injection, and the ringer means in the human body.
【0118】 In the present invention, the above-mentioned graphene is graphite,
and carbon 0.1nm to the powder made with 1nm.
【0119】 The aggregate of the size in which the powders of 0.1nm to 1nm are
mixed can be used when using the graphene powder, and the organism
graphene powder.
【0120】 Or the population powder of the size selected in the size of the powder
of 0.1nm to 1nm can be used when using the graphene powder, and the
organism graphene powder.
【0121】 In the present invention, the nanopowder which it generally can use of
the graphene
【0122】 The carbon-powder of 0.1nm to 1nm.
【0123】 The calcium powder of 0.1nm to 1nm.
【0124】 The zinc powder of 0.1nm to 1nm.
【0125】 The magnesium powder of 0.1nm to 1nm.
【0126】 The iron powder of 0.1nm to 1nm.
【0127】 It has the inorganic powder of 0.1nm to 1nm etc.
【0128】 It has the organic material powder of 0.1nm to 1nm etc.
【Reference Signs List】
【0129】 The body (10) spike protrusion (12)
Graphene powder (20) virus (100)
18. 【Claims】
【Claim 1】
The saline solution in which the graphene which adds the graphene powder
in the saline solution and which disperses and configured is dispersed and
contained.
【Claim 2】
The saline solution in which the graphene which adds the organism graphene
powder in the saline solution and which disperses and configured is dispersed
and contained.
【Claim 3】
The saline solution in which the saline solution can be the dextrose in water,
the Ringer`s solution, and the injection solution and one graphene is dispersed
and contained.
【Claim 4】
The saline solution in which the saline solution is the water means which
human can drink and one graphene is dispersed and contained.
【Claim 5】
The saline solution in which the graphene which the graphene powder , and
the size of the organism graphene powder are done by the aggregate of the
powders of size less than 0.01nm to 1nm is dispersed and contained.
【Claim 6】
Among the graphene powder, and the size of the organism graphene powder is
the powders of size less than 0.01nm to 1nm.
The saline solution in which the graphene which it is done by the aggregate of
the specific size is dispersed and contained.
19. 【Claim 7】
Among the graphene powder, and the size of the organism graphene powder is
the powders of size less than 0.01nm to 5nm.
The saline solution in which the graphene which it is done by the aggregate of
the specific size is dispersed and contained.
【Claim 8】
The saline solution in which the graphene in which the graphene powder or
the amount in which the organism graphene is dispersed and which is added
can add the specific weight in which the graphene powder is selected in the
interval of about 0.000005g to 1g in the saline solution in the saline solution 1L
is dispersed and contained.
【Claim 9】
The saline solution in which with it is the nanopowder of the organic material
or the inorganic material one graphene is generally dispersed and contained of
the graphene powder or the organism graphene powder.
【Claim 10】
The saline solution in which the graphene powder is dispersed and contained.
Or the saline solution in which the graphene scanning the saline solution
in which the organism graphene powder is dispersed and contained on the
human body and the disease to the prevention or the Intention-to-treat is
dispersed and contained.
【Claim 11】
The eating material in which the graphene powder is dispersed and contained.
Or the saline solution in which the eating material in which the organism
graphene powder is dispersed and contained drinks to the oral cavity and
preventing the disease or with it is the Intention-to-treat in which one
20. graphene is or dispersed and contained.
【Claim 12】
The saline solution in which the graphene powder is dispersed and contained.
Or the saline solution in which the organism graphene powder is dispersed and
contained
Or the eating material in which the graphene powder is dispersed and
contained
Or the saline solution in which the graphene vaporizing to steam to the
vaporizing apparatus being selected from the eating material in which the
organism graphene powder is dispersed and contained and sends to the
respiratory process to the lungs and the disease is cured is dispersed and
contained.
【Claim 13】
The saline solution in which the graphene powder is dispersed and contained.
Or the saline solution in which the organism graphene powder is dispersed and
contained
Or the eating material in which the graphene powder is dispersed and
contained
Or the saline solution in which the graphene fogging to the high-volfage
device being selected from the eating material in which the organism graphene
powder is dispersed and contained and sends to the respiratory process to the
lungs and the disease is cured is dispersed and contained.
21. 【Abstract】
【Summary】
The present invention relates to the injection solution, the saline solution, the
dextrose in water, the Ringers solution placed with the purpose of curing the
disease on the blood vessel of the human body, and the subcutaneous tissue.
The saline solution in which the graphene of the invention is dispersed and
contained tries to utilize for each disease including the dementia disease,
parkinson's disease, amyotrophic lateral sclerosis, the Huntington disease etc.
The saline solution in which the graphene of the invention is dispersed and
contained tries to utilize as the therapeutic agent of the etc. virus as ***,
SARS, and the nose.
The graphene powder of size less than 0.2nm in the means of using as the
injection solution, the Ringers solution, the saline solution, the injection
solution including the dextrose in water etc used in the conventional hospital
can be used as the therapeutic agent it is scattered.
If the Ringers solution in which the graphene powder is dispersed is injected
into the human body in which the virus percolates and it is evenly propagated
to the interior of the body and the virus and graphene powder meet, the
graphene powder and virus attract into the nano cohesive force and it sticks.
If the body stick because the graphene powder sweets on the body and spike
protrusion of the virus, it is unable to function and the virus is unable to
increase and it dies out in the satellite exchange.
【Representative Drawing】
Figure2